|
|
Proto-Oncogene Proteins c-fos
Research News and Information
Definition of 'Proto-Oncogene Proteins c-fos'Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes. Common names: Proto-Oncogene Proteins c-fos; Proto Oncogene Proteins c fos; fos Proto-Oncogene Proteins; fos Proto Oncogene Proteins; Proto-Oncogene Proteins fos; Proto Oncogene Proteins fos; p55(c-fos); Proto-Oncogene Products c-fos; Proto Oncogene Products c fos; c-fos Proteins; c fos Proteins; p55 c-fos |
Saturday, November 21, 2009
Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents.
30 Oct 2009
BACKGROUND: One underexploited property of anesthetics is their ability to probe neuronal regulation of arousal. At appropriate doses, anesthetics reversibly obtund conscious perception. However, individual anesthetic agents may accomplish this by ... Read more...
30 Oct 2009
BACKGROUND: Fos expression in the lumbar spinal cord, resulting from a noxious electrical stimulus at the hindpaw, is hypothesized to originate from three sources: direct sensory input of the noxious stimulus, local interactions in the spinal cord, ... Read more...
19 Oct 2009
Nociceptive stimulation elicits neuroendocrine responses such as arginine vasopressin (AVP) release as well as activation of the hypothalamo-pituitary-adrenal axis. We have generated novel transgenic rats expressing an AVP-enhanced green fluorescent ... Read more...
Latest indexed articles for 'Proto-Oncogene Proteins c-fos'
These are the very latest articles for this heading:
- Halothane-induced hypnosis is not accompanied by inactivation of orexinergic output in rodents.
30 Oct 2009 - The effect of a thoracic spinal block on fos expression in the lumbar spinal cord of the rat induced by a noxious electrical stimulus at the hindpaw.
30 Oct 2009 - Exaggerated response of a vasopressin-enhanced green fluorescent protein transgene to nociceptive stimulation in the rat.
19 Oct 2009 - Retrograde viral vector-mediated inhibition of pontospinal noradrenergic neurons causes hyperalgesia in rats.
12 Oct 2009 - Autocrine activation of neuronal NMDA receptors by aspartate mediates dopamine- and cAMP-induced CREB-dependent gene transcription.
5 Oct 2009 - Double dissociation and hierarchical organization of strategy switches and reversals in the rat PFC.
29 Sep 2009 - c-Fos expression associated with reinstatement of cocaine-seeking behavior by response-contingent conditioned cues.
29 Sep 2009 - Licking decreases phosphorylation of extracellular signal-regulated kinase in the dorsal horn of the spinal cord after a formalin test.
29 Sep 2009 - Parallel preoptic pathways for thermoregulation.
21 Sep 2009 - Histone crosstalk between H3S10ph and H4K16ac generates a histone code that mediates transcription elongation.
16 Sep 2009 - Aldosterone-induced activation of signaling pathways requires activity of angiotensin type 1a receptors.
15 Sep 2009 - Immunotoxin-induced ablation of melanopsin retinal ganglion cells in a non-murine mammalian model.
8 Sep 2009 - Functional requirement of AgRP and NPY neurons in ovarian cycle-dependent regulation of food intake.
31 Aug 2009 - The immediate-early oncoproteins Fra-1, c-Fos, and c-Jun have distinguishable surface behavior and interactions with phospholipids.
30 Aug 2009 - Estrogen receptor regulates MyoD gene expression by preventing AP-1-mediated repression.
29 Aug 2009 - RSK is a principal effector of the RAS-ERK pathway for eliciting a coordinate promotile/invasive gene program and phenotype in epithelial cells.
26 Aug 2009 - Granular and dysgranular retrosplenial cortices provide qualitatively different contributions to spatial working memory: evidence from immediate-early gene imaging in rats.
25 Aug 2009 - DNA-based MRI probes for specific detection of chronic exposure to amphetamine in living brains.
24 Aug 2009 - The ubiquitin-interacting motifs of S5a as a unique upstream inhibitor of the 26S proteasome.
16 Aug 2009 - Hyperactivated NF-{kappa}B and AP-1 transcription factors promote highly accessible chromatin and constitutive transcription across the interleukin-6 gene promoter in metastatic breast cancer cells.
15 Aug 2009
See a longer list of these articles.
Technical information about 'Proto-Oncogene Proteins c-fos'
Definition: Cellular DNA-binding proteins encoded by the c-fos genes (GENES, FOS). They are involved in growth-related transcriptional control. c-fos combines with c-jun (PROTO-ONCOGENE PROTEINS C-JUN) to form a c-fos/c-jun heterodimer (TRANSCRIPTION FACTOR AP-1) that binds to the TRE (TPA-responsive element) in promoters of certain genes.
Registry Number: 0
Descriptor UI: D016760
Alternative terms: Proto-Oncogene Proteins c-fos; Proto Oncogene Proteins c fos; fos Proto-Oncogene Proteins; fos Proto Oncogene Proteins; Proto-Oncogene Proteins fos; Proto Oncogene Proteins fos; p55(c-fos); Proto-Oncogene Products c-fos; Proto Oncogene Products c fos; c-fos Proteins; c fos Proteins; p55 c-fos; p55 c fos; Fos B Protein; Antigens, Fos-Related; FRAs; Fos-Related Antigens; Fos Related Antigens;
Related Mesh Headings: Transcription Factor AP-1;
Allowable Qualifiers: administration & dosage; adverse effects; analysis; antagonists & inhibitors; biosynthesis; blood; cerebrospinal fluid; chemical synthesis; classification; deficiency; diagnostic use; drug effects; economics; genetics; history; immunology; isolation & purification; metabolism; pharmacokinetics; pharmacology; physiology; poisoning; radiation effects; secretion; standards; supply & distribution; therapeutic use; toxicity; ultrastructure; urine; chemistry; contraindications; agonists;
Tree Number: D12.776.260.108.765; D12.776.624.664.700.179; D12.776.660.760; D12.776.930.127.765;
Online Note: use PROTO-ONCOGENE PROTEINS C-FOS (NM) to search PROTO-ONCOGENE PROTEIN FOS (NM) 1985-91 & FOS B PROTEIN (NM) 1990-91
History Note: 92; was PROTO-ONCOGENE PROTEIN FOS (NM) 1985-91; FOS B PROTEIN was FOS B PROTEIN (NM) 1990-91
Technical Notes: /drug eff /ultrastruct permitted; not for c-fos 39 ( = C-FOS-ASSOCIATED PROTEIN P39 see PROTO-ONCOGENE PROTEINS C-JUN); DF: note short X refs